Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery.
about
Targeted Therapy in Oropharyngeal Squamous Cell Carcinoma: The Implications of HPV for TherapyAn updated overview of HPV-associated head and neck carcinomasEvaluation of a novel non-penetrating electrode for use in DNA vaccinationPhysical energy for drug delivery; poration, concentration and activation.Physically facilitating drug-delivery systems.Immunogenicity of a trivalent human papillomavirus L1 DNA-encapsidated, non-replicable baculovirus nanovaccine.Optimization of electroporation-enhanced intradermal delivery of DNA vaccine using a minimally invasive surface device.Control of HPV-associated tumors by innovative therapeutic HPV DNA vaccine in the absence of CD4+ T cells.Immunologic responses to xenogeneic tyrosinase DNA vaccine administered by electroporation in patients with malignant melanomaDNA vaccines for cervical cancerEnhancing DNA vaccine potency by co-administration of xenogenic MHC class-I DNA.Spontaneous and Vaccine-Induced Clearance of Mus Musculus Papillomavirus 1 InfectionTherapeutic HPV DNA vaccines.Perspectives for preventive and therapeutic HPV vaccines.Immunotherapy for cervical cancer: Research status and clinical potentialStrategies for cancer vaccine development.Tumor-targeted delivery of IL-2 by NKG2D leads to accumulation of antigen-specific CD8+ T cells in the tumor loci and enhanced anti-tumor effects.Toll-like receptor agonist imiquimod facilitates antigen-specific CD8+ T-cell accumulation in the genital tract leading to tumor control through IFNγImmunogenicity of bivalent human papillomavirus DNA vaccine using human endogenous retrovirus envelope-coated baculoviral vectors in mice and pigs.Improvement of different vaccine delivery systems for cancer therapy.Enhancement of protein vaccine potency by in vivo electroporation mediated intramuscular injection.Immunologic response to xenogeneic gp100 DNA in melanoma patients: comparison of particle-mediated epidermal delivery with intramuscular injection.Xenogeneic human p53 DNA vaccination by electroporation breaks immune tolerance to control murine tumors expressing mouse p53.Characterization of the methylation patterns in human papillomavirus type 16 viral DNA in head and neck cancers.DNA vaccine with α-galactosylceramide at prime phase enhances anti-tumor immunity after boosting with antigen-expressing dendritic cellsModulation of SIV and HIV DNA vaccine immunity by Fas-FasL signalingTrial watch: Naked and vectored DNA-based anticancer vaccinesIntravaginal HPV DNA vaccination with electroporation induces local CD8+ T-cell immune responses and antitumor effects against cervicovaginal tumors.Biology of human papillomavirus infection and immune therapy for HPV-related head and neck cancers.Induction of robust cellular immunity against HPV6 and HPV11 in mice by DNA vaccine encoding for E6/E7 antigen.DNA vaccines, electroporation and their applications in cancer treatmentTrial watch: DNA vaccines for cancer therapy.Promising systemic immunotherapies in head and neck squamous cell carcinoma.HPV infection: immunological aspects and their utility in future therapyDevelopment of a DNA vaccine targeting Merkel cell polyomavirusA bis-benzylidine piperidone targeting proteasome ubiquitin receptor RPN13/ADRM1 as a therapy for cancer.Direct T cell activation via CD40 ligand generates high avidity CD8+ T cells capable of breaking immunological tolerance for the control of tumors.Electroporation delivery of DNA vaccines: prospects for successRecent advances in immunotherapy for the treatment of prostate cancer.Prostate cancer vaccines.
P2860
Q26824925-CCC63E2C-DFAE-4749-A07E-01B84086E9B9Q27014019-ADF439FF-3F41-4A45-BCDF-FBC031D6E1EEQ28740588-7494CE4A-715F-43CB-86B4-33B4E14A4957Q30412855-E209EABA-A6BA-4666-B06B-592DEED5DC28Q30462003-2146111E-55E9-4E8C-88A1-F4AE13A278DBQ31159398-C1D9F56E-DCC7-47F7-8176-0223A79362DDQ33586294-1D6772A4-47AF-4B17-A4E4-484EB1764F7FQ33589738-36B8236F-25B8-4DFB-B0B6-13379EBFB230Q33606137-D7207BF2-6E27-495E-AC77-B62DAA4855C7Q33680693-4F3F4AEE-799A-4DE2-85A1-819F40F0714EQ33778143-871BB427-0FD3-434D-8F61-966DEF510D23Q33907700-5C1DBD3D-9CE0-4E67-B284-24754550ADFBQ33936427-6CEC29D0-BD22-457E-9522-3E8E19B0200CQ34011494-2EE454E0-E6AD-458B-8A70-B49D0BD4101DQ34033763-7F5695E2-D4F3-4650-9C03-6268F8E9CF48Q34038338-FCB1FB23-C492-4DF9-99A5-C8EE7B64E9DEQ34235597-EFDADB39-F246-4B54-9A54-D092D5B86204Q34438411-4AA4A5B6-A333-4C49-A2D9-D7B58A4BA927Q34500100-C9D0BE5C-3BCB-498A-9BE4-457821E8C306Q34506877-09F8758C-CF8B-4F4E-B5ED-D580F14CBED6Q34516610-005BB670-5F61-4381-A05F-4095F01C43A1Q34561877-D83BA4B7-582C-4414-BE30-178AB776768CQ34607207-E24B1E49-7A55-4E76-9168-9FE54D965F0EQ34813512-789F8634-C799-4C37-96E3-2105BB480016Q35148074-6021F032-B0CB-4E1F-9E1F-652F9587460AQ35232840-4A35CC6A-D8BD-4D99-A07E-3A82C6FC1D81Q35798986-69E77711-8CC2-4F04-A1AA-78E62397E3D5Q35812239-08462DCA-D14C-4685-AD87-509002338774Q36099498-68088114-3495-4A1B-9E74-459C657C946EQ36184362-4277BB6C-7612-4778-8EEC-7CB0BBA36469Q36256459-1E1CED0D-D983-43F7-AA89-56E9C3B081FBQ36845824-FD9E62F7-58C8-4295-B6DF-1B6F93F0E69CQ36883848-68658300-82C8-4264-BEE9-4627C8F4086CQ37145093-C1702662-1711-4056-A2C5-F6D2B1FE6A15Q37200390-F6D16793-7FC1-45CD-8131-5D65FB9074FAQ37435436-1CAAD564-0F39-4B34-9366-710AD9C54BE1Q37659577-D19E3550-2F3D-4CEB-BA82-B82B1DBC8054Q37870313-CE5507B5-A1FB-47F1-A56A-DC420638EB68Q37889984-A97B03E9-982D-4F74-AD73-6DA14DF6290FQ38089935-C2665976-4102-44E4-8DF3-C0BD40612BE8
P2860
Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Administration of HPV DNA vacc ...... intradermal gene gun delivery.
@en
Administration of HPV DNA vacc ...... intradermal gene gun delivery.
@nl
type
label
Administration of HPV DNA vacc ...... intradermal gene gun delivery.
@en
Administration of HPV DNA vacc ...... intradermal gene gun delivery.
@nl
prefLabel
Administration of HPV DNA vacc ...... intradermal gene gun delivery.
@en
Administration of HPV DNA vacc ...... intradermal gene gun delivery.
@nl
P2093
P2860
P1433
P1476
Administration of HPV DNA vacc ...... intradermal gene gun delivery.
@en
P2093
Chi-Mou Juang
Chien-Fu Hung
Drew Hannaman
John R Saunders
Sara I Pai
Shiwen Peng
Simon R Best
P2860
P304
P356
10.1016/J.VACCINE.2009.07.005
P407
P577
2009-07-19T00:00:00Z